Simon Herriott
CIK 1843592 · View on SEC EDGAR ↗
Insider
First SEC filing: April 21, 2021 · Latest: April 21, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 71 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
71 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2021 | IFF | S | 1,332 | $138.47 | $184,442 | 1,515 Direct | -46.79% | Disposed | -39.8% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 3, 2024 | IFF | Restricted Stock Units | Common Stock (627) | — | — | 627 | Disposed |
| May 3, 2024 | IFF | Restricted Stock Units | Common Stock (1,591) | — | — | 1,591 | Disposed |
| May 1, 2024 | IFF | Restricted Stock Units | Common Stock (8,930) | — | — | 8,930 | Acquired |
| April 5, 2024 | IFF | Restricted Stock Units | Common Stock (1,244) | — | — | 1,244 | Disposed |
| April 5, 2024 | IFF | Restricted Stock Units | Common Stock (346) | — | April 5, 2024 | 346 | Disposed |
| April 1, 2024 | IFF | Restricted Stock Units | Common Stock (1,489) | — | — | 1,489 | Disposed |
| July 3, 2023 | IFF | Restricted Stock Units | Common Stock (1,881) | — | — | 1,881 | Acquired |
| May 3, 2023 | IFF | Restricted Stock Units | Common Stock (4,774) | — | — | 4,774 | Acquired |
| April 1, 2023 | IFF | Restricted Stock Units | Common Stock (1,489) | — | — | 1,489 | Disposed |
| Feb. 19, 2023 | IFF | Restricted Stock Units | Common Stock (617) | — | — | 617 | Disposed |
| May 4, 2022 | IFF | Purchased Restricted Stock Units | Common Stock (2,988) | — | April 4, 2025 | 2,988 | Acquired |
| May 4, 2022 | IFF | Restricted Stock Units | Common Stock (1,660) | — | April 4, 2025 | 1,660 | Acquired |
| April 1, 2022 | IFF | Restricted Stock Units | Common Stock (2,978) | — | — | 2,978 | Acquired |
| Feb. 19, 2022 | IFF | Restricted Stock Units | Common Stock (616) | — | — | 616 | Disposed |
| Feb. 14, 2022 | IFF | Restricted Stock Units | Common Stock (525) | — | — | 525 | Disposed |
| Dec. 31, 2021 | IFF | Restricted Stock Units | Common Stock (3,241) | — | Dec. 31, 2021 | 3,241 | Disposed |
| May 13, 2021 | IFF | Stock Options (right to buy) | Common Stock (1,513) | $115.48 | Feb. 3, 2022 | 1,513 | Disposed |
| May 5, 2021 | IFF | Purchased Restricted Stock Units | Common Stock (1,244) | — | April 5, 2024 | 1,244 | Acquired |
| May 5, 2021 | IFF | Restricted Stock Units | Common Stock (346) | — | April 5, 2024 | 346 | Acquired |
| Feb. 19, 2021 | IFF | Restricted Stock Units | Common Stock (616) | — | — | 616 | Disposed |
| Feb. 15, 2021 | IFF | Restricted Stock Units | Common Stock (105) | — | Feb. 15, 2021 | 105 | Disposed |
| Feb. 14, 2021 | IFF | Restricted Stock Units | Common Stock (525) | — | — | 525 | Disposed |
| Feb. 14, 2021 | IFF | Restricted Stock Units | Common Stock (525) | — | — | 525 | Disposed |
| Feb. 1, 2021 | IFF | Restricted Stock Units | Common Stock (1,849) | — | — | 1,849 | Acquired |
| Feb. 1, 2021 | IFF | Restricted Stock Units | Common Stock (1,050) | — | — | 1,050 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (1,356) | $149.65 | Feb. 14, 2028 | 1,356 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (2,823) | $77.16 | Feb. 18, 2030 | 2,823 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (3,202) | $123.76 | Feb. 1, 2027 | 3,202 | Acquired |
| Feb. 1, 2021 | IFF | Restricted Stock Units | Common Stock (5,547) | — | — | 5,547 | Acquired |
| Feb. 1, 2021 | IFF | Restricted Stock Units | Common Stock (2,100) | — | — | 2,100 | Acquired |
| Feb. 1, 2021 | IFF | Restricted Stock Units | Common Stock (105) | — | Feb. 15, 2021 | 105 | Acquired |
| Feb. 1, 2021 | IFF | Restricted Stock Units | Common Stock (3,241) | — | Dec. 31, 2021 | 3,241 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (4,068) | $149.65 | Feb. 14, 2028 | 4,068 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (8,469) | $77.16 | Feb. 18, 2030 | 8,469 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (9,606) | $123.76 | Feb. 1, 2027 | 9,606 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (1,513) | $115.48 | Feb. 3, 2022 | 1,513 | Acquired |
| Feb. 1, 2021 | IFF | Stock Options (right to buy) | Common Stock (11,702) | $95.28 | Aug. 5, 2029 | 11,702 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 21, 2021 | IFF | Common Stock | 481 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
IFF
President, Health & Biosciences| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $674,850 | — | — | — | $1,038,259 | $25,738 | $87,975 | $3,326,855 |
| 2023 | $634,500 | — | $1,199,971 | — | $480,146 | — | $77,030 | $2,391,647 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.